Navigation Links
Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
Date:9/26/2013

SAN DIEGO, Sept. 26, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the commercial launch of Herceptin® SC in Europe has triggered a $10 million milestone payment to Halozyme under the License and Collaboration Agreement between Halozyme and Roche. This time-saving subcutaneous formulation of Herceptin (trastuzumab) using Halozyme's recombinant human hyaluronidase (rHuPH20) received marketing authorization from the European Commission on August 28, 2013 for the treatment of patients with HER2-positive breast cancer and was launched upon approval. Herceptin SC reduces treatment times and enhances convenience compared to the standard intravenous (IV) form.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"With pricing on par with the intravenous formulation, Herceptin SC represents a compelling treatment alternative for breast cancer patients in Europe, and we congratulate Roche on making this time-saving therapy available to patients in Europe so quickly," said Gregory I. Frost, Ph.D., President and Chief Executive Officer of Halozyme.  "This will be the third commercial product using our rHuPH20 enzyme and represents a significant achievement for our technology and company as a whole."

About Breast Cancer
Breast cancer is the most common cancer among women worldwide.1 Each year, about 1.4 million new cases of breast cancer are diagnosed worldwide, and over 450,000 women will die of the disease annually.1 In HER2-positive breast cancer, increased quantities of the human epidermal growth factor receptor 2 (HER2) are present on the surface of the tumor cells. Thi
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
4. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
5. New Executive Vice President Commercial Appointed
6. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
7. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
8. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
11. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the "Physician Office Laboratory Markets, 3rd ... This report, Physician Office Laboratory Markets is ... the IVD industry. Physician office laboratories are diverse ... simply perform reimbursable, in-office pregnancy and glucose tests. ...
(Date:9/23/2014)... , Sept. 23, 2014 The Pennsylvania State ... Sat., Sept. 27, as part of National Prescription Drug ... questions asked. Take-Back Day is a national ... Administration (DEA), aimed at encouraging the public to dispose ... prone to abuse and theft. From 10 ...
(Date:9/23/2014)... 23, 2014 Research and Markets ... Vaccine Production Markets" report to their offering. ... and vaccines - including products to treat cancer, diabetes, ... challenges during the final stages of clinical drug testing ... to risk production capital to upscale while anticipating FDA ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3
... Top-line Data to be Released Concurrent with November 9 AHA Data ... ... (Nasdaq: VIAP ), a biotechnology company focused on the development of,compounds ... last patient visit in its Phase 2 acute coronary,syndrome (ACS) study, including ...
... and Efficacy of ORMD 0801, Oral Insulin Capsule, ... on Type 1 ... http://www.oramed.com ), a developer,of oral delivery systems, announced today that it has ... 1 diabetics at the,Hadassah University Medical Center in Jerusalem, Israel., Oramed,s ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2
(Date:9/23/2014)... York (PRWEB) September 23, 2014 Mirena ... injury due to spontaneous migration of the birth control ... Bernstein Liebhard LLP reports. According to court documents dated ... that alleges migration of the IUD outside of the ... rectum. Her lawsuit, which is now pending in the ...
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... Florida Hospital Zephyrhills officially celebrates the ... Center on Wednesday, September 24. With more than ... center offers a new level of personalized care ... Health Center offers comprehensive women’s services including gynecology, ... through The Baby Place®, and breast care through ...
(Date:9/23/2014)... TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS ... WHAT: , The National Institutes of Health is convening ... scientific evidence on the long-term effectiveness and potential risks ... among the nation,s top experts in the field of ... well as key NIH scientists who focus on pain ...
(Date:9/23/2014)... (PRWEB) September 24, 2014 From first-hand ... disorder (PTSD) – and how it can be treated. ... deployed in Iraq in 2006. His platoon sustained multiple ... 2008, he was diagnosed with combat-related PTSD and honorably ... was angry, and I had distanced myself from my ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3
... Former Steeler Robin Cole to Appear , , ... be Saturday, August 8, as Experience LEBO and Miller Lite present ... party event, from 8 p.m. to midnight. , , ... to literally party in the street-- Rt. 19/Washington Road closes to vehicular traffic ...
... , FERNDALE, Wash., July 28 Nearly 64 ... vitamin D - a nutrient found to support the immune system, bone strength, ... , manufacturers of a liquid vitamin D3 supplement. , , ... aware that sunscreen, even at SPF15, blocks more than 90 percent of the ...
... , , , ... health care providers and nonprofit health plans, announced today that it ... more than 700 nonprofit agencies nationwide in the second quarter of ... access to high-quality care to uninsured and underserved communities, healthy food ...
... , , LOS ANGELES, ... of next generation digital media protection and intelligence solutions, today ... technology platform to ensure network protection and data security for ... companies, pharmaceutical companies, hospitals, physician practices, and more. In ...
... study by researchers at the Georgetown,s Lombardi Comprehensive Cancer Center ... urine of children with acute lymphoblastic leukemia (ALL), a cancer ... age. The findings are published in the August issue ... caution that these findings should not be seen as cause-and-effect, ...
... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
Cached Medicine News:Health News:Mt. Lebanon Comes Alive Saturday, August 8th with ULTRAparty 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 2Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 4Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 5Health News:Nexicon Technology to Protect Healthcare Industry 2Health News:Nexicon Technology to Protect Healthcare Industry 3Health News:Nexicon Technology to Protect Healthcare Industry 4Health News:Nexicon Technology to Protect Healthcare Industry 5Health News:Common household pesticides linked to childhood cancer cases in Washington area 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: